US equities |
NVDA $187.24 ▼-6.44% TSLA $350.23 ▼-9.08% MU $724.95 ▼-8.84% SPCX $124.33 ▼-8.53% AAPL $349.85 ▲+0.10% AMZN $258.54 ▼-2.82% AMD $434.76 ▼-11.05% META $598.36 ▼-5.02%
FinancialContent

Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.225 -0.065 (-1.98%)
Delayed Quote Updated: 9:50 AM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
23 24 Next >
News headline image
Earnings Preview For Ardelyx ↗
 
Via Benzinga
News headline image
Ardelyx Announces Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with IBS-C, to be Presented at the 2023 Digestive Disease Week Conference
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Report First Quarter 2023 Financial Results and Provide Business Update on May 3, 2023
Conference call scheduled for 4:30 p.m. Eastern Time 
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx Inc. (NASDAQ: ARDX) is a Stock Spotlight on 4/18
Via Investor Brand Network
Ardelyx Inc. (NASDAQ: ARDX) is a Stock Spotlight on 4/13
Via Investor Brand Network
Ardelyx Inc. (NASDAQ: ARDX) is a Stock Spotlight on 4/5
Via Investor Brand Network
Ardelyx Inc. (NASDAQ: ARDX) is a Stock Spotlight on 4/3
Via Investor Brand Network
Ardelyx Inc. (NASDAQ: ARDX) is a Stock Spotlight on 3/30
Via Investor Brand Network
News headline image
Ardelyx Resubmits New Drug Application to U.S. Food and Drug Administration for XPHOZAH® (tenapanor)
Company expects to receive goal review date in mid-May 
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH® (tenapanor) at National Kidney Foundation 2023 Spring Clinical Meetings
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Analyst Upgrades This Stock And Doubles Price Target On Encouraging Ibsrela Story ↗
 
Via Benzinga
News headline image
Why Is Ardelyx (ARDX) Stock Up 25% Today? ↗
Ardelyx swung from an earnings loss to a profit and an analyst took notice of the company's progress. Now, ARDX stock is catching a bid. 
Via InvestorPlace
News headline image
3 Penny Stocks to Add to Your Watchlist for Potential Breakouts ↗
These penny stocks are catching the attention of big-money investors as they continue to build up momentum for a potential breakout. 
Via InvestorPlace
News headline image
7 A-Rated Stocks to Buy for April 2023 ↗
Now that the first quarter's in the bank, here are seven A-rated stocks to buy for April to keep your portfolio in top-notch shape. 
Via InvestorPlace
News headline image
7 Core Stocks to Build a Solid Portfolio Around ↗
You’ll enjoy your investing journey more if you know that you can rely on your core of stocks to buy to provide a solid foundation. 
Via InvestorPlace
News headline image
Dow Jumps Over 300 Points; S&P 500 Rises 1.5% ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Friday. The Dow traded up 1.03% to 33,343.73 while the NASDAQ rose 1.92% to 11,682.86. The S&P... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. 
Via Benzinga
News headline image
Nasdaq Up 150 Points; Crude Oil Rises 1% ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Friday. The Dow traded up 0.59% to 33,197.08 while the NASDAQ rose 1.32% to 11,614.60. The S&P... 
Via Benzinga
News headline image
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Ardelyx Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Publishes First Environmental, Social and Governance (ESG) Report
Report focuses on patient access and affordability, workforce wellness and training, community involvement and sound corporate governance 
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
7 Smart Stock Picks for Cautious Investors ↗
As market volatility continues, consider playing it safe with these seven high-quality stocks for cautious investors. 
Via InvestorPlace
News headline image
Ardelyx to Participate at the Cowen 43rd Annual Health Care Conference
From Ardelyx, Inc.
Via GlobeNewswire
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
23 24 Next >